Search Results - Philipp Al Ghazal
- Showing 1 - 2 results of 2
-
1
Associated factors and comorbidities in patients with pyoderma gangrenosum in Germany: a retrospective multicentric analysis in 259 patients by Philipp Al Ghazal, Katharina Herberger, Jörg Schaller, Anke Strölin, Norman‐Philipp Hoff, Tobias Goerge, Hannelore Roth, Eberhard Rabe, Sigrid Karrer, Regina Renner, Jan Maschke, Thomas Horn, Julia Hepp, Sabine A. Eming, Uwe Wollina, Markus Zutt, Isabell Sick, Benno Splieth, Dorothea Dill, Joachim Klode, Joachim Dissemond
Published 2013Artigo -
2
Differential influence of vemurafenib and dabrafenib on patients’ lymphocytes despite similar clinical efficacy in melanoma by Bastian Schilling, Wiebke Sondermann, Fang Zhao, Klaus Griewank, Elisabeth Livingstone, Antje Sucker, Henning Zelba, Benjamin Weide, Uwe Trefzer, Tabea Wilhelm, Carmen Loquai, Carola Berking, Jessica C. Hassel, Katharina C. Kähler, Jochen Utikal, Philipp Al Ghazal, Ralf Gutzmer, Simone M. Goldinger, Lisa Zimmer, Annette Paschen, Uwe Hillen, Dirk Schadendorf
Published 2014Artigo
Search Tools:
Related Subjects
Dermatology
Internal medicine
Medicine
Biology
Cancer research
Dabrafenib
Diabetes mellitus
Disease
Endocrine system
Endocrinology
Environmental health
Genetics
Hormone
Inflammatory bowel disease
Kinase
MAPK/ERK pathway
Melanoma
Metastatic melanoma
Oncology
Population
Pyoderma gangrenosum
Retrospective cohort study
Trametinib
Vemurafenib